Insider trade

Veracyte, Inc. (VCYT): Director sold ~$81K

Muna Bhanji, Director at Veracyte, Inc., sold ~$81K of Veracyte, Inc. shares.

~$81K
Approx. value · 1,864 sh @ $43.70
41K
Holds after · shares reported
Traded
Oct 19, 2026
Filed
Oct 20, 2026

What stands out in this filing

  • The sale was 4.4% of the shares this insider held before it; the filing reports 40,854 shares afterwards.
  • 1,864 shares at an average of $43.70 each, as reported on the form.
  • Footnote references a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 23, 2025Federal contract · $130K obligatedDepartment of Veterans Affairs awarded VERACYTE, INC.: $130K obligated to date
  2. Jan 8, 2026Federal contract · $345K obligatedDepartment of Veterans Affairs awarded VERACYTE, INC.: $345K obligated to date
  3. Sep 10, 2026Company filing · Form 8-K · Material agreement, Acquisition or saleCompleted buying or selling a business or assets, and signed an important agreement (and 1 more item)“On September 14, 2026, Veracyte completed its acquisition of Convergent pursuant to the terms of the Merger Agreement. To the extent required by this Item 2.01, the information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this”
  4. Sep 24, 2026InsiderDirector sold ~$353K of VCYT shares in the open market
  5. Oct 19, 2026 · this disclosureInsiderDirector sold ~$81K of VCYT shares in the open market

What came next

  1. Oct 27, 2026Insider · 2 peopleInsiders: 2 sales (~$1.1M)
  2. Nov 4, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  3. Nov 5, 20265% stakeFMR LLC reported a passive stake (13G) of 7.7%
  4. Nov 12, 20265% stakeArtisan Partners Asset Management Inc. reported a passive stake (13G) of 2.9%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Veracyte, Inc.

For Veracyte, Inc., OQRO holds 6 insider filings (SEC Form 4 or Form 144), 3 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VCYT page.

Other recent filings by Muna Bhanji, Director

The full history of Muna Bhanji, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Veracyte, Inc. (VCYT) insider traded, and how much?

Muna Bhanji, Director at Veracyte, Inc., sold ~$81K of Veracyte, Inc. shares. 1,864 shares at $43.70.

When did it happen, and when was it made public?

Traded: Oct 19, 2026. Filed: Oct 20, 2026. That is 1 day between the two dates.

What stands out in this filing?

The sale was 4.4% of the shares this insider held before it; the filing reports 40,854 shares afterwards. 1,864 shares at an average of $43.70 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Veracyte, Inc. recently?

For Veracyte, Inc., OQRO holds 6 insider filings (SEC Form 4 or Form 144), 3 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days. They are listed on the VCYT page.

Does this mean VCYT stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Veracyte, Inc.

Everything OQRO holds on this company is on its VCYT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data